tiprankstipranks
CNS Pharmaceuticals Strives to Regain Nasdaq Compliance
Company Announcements

CNS Pharmaceuticals Strives to Regain Nasdaq Compliance

Pick the best stocks and maximize your portfolio:

CNS Pharmaceuticals (CNSP) has provided an announcement.

CNS Pharmaceuticals, Inc. faces a challenge maintaining its Nasdaq listing after the stock price fell below the $1 minimum bid requirement for 30 days. While there’s no immediate threat to its listing, the company must boost its share price to meet Nasdaq’s standards by August 26, 2024, or potentially undergo measures like a reverse stock split. This comes alongside the appointment of new members to its Board committees, signaling internal shifts as the company navigates financial compliance issues.

For a thorough assessment of CNSP stock, go to TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskCNS Pharmaceuticals Hosts Virtual Analyst and Investor Day
TheFlyCNS Pharmaceuticals presents update from ongoing study of berubicin
TheFlyCNS Pharmaceuticals reports Q3 EPS (25c) vs. ($54.14) last year
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App